Works matching DE "AIT Group PLC"

Days with severe symptoms: an additional efficacy endpoint in immunotherapy trials.

Published in:

Allergy, 2011, v. 66, n. 1, p. 120, doi. 10.1111/j.1398-9995.2010.02434.x

By:

• Durham, S. R.;
• Birk, A. O.;
• Andersen, J. S.

Publication type:

Article